Corpus ID: 79119303

Preclinical evaluation of Meriva (a formulation of curcumin) as a putative agent for chemoprevention of lung cancer

@inproceedings{Mahale2016PreclinicalEO,
  title={Preclinical evaluation of Meriva (a formulation of curcumin) as a putative agent for chemoprevention of lung cancer},
  author={J. Mahale},
  year={2016}
}
3 Citations

References

SHOWING 1-10 OF 322 REFERENCES
Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.
  • 500
  • Highly Influential
  • PDF
Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics
  • 33
  • Highly Influential
Potential biomarkers for lung cancer screening.
  • 43
  • Highly Influential
  • PDF
The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
  • 185
  • Highly Influential
Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation.
  • 227
  • Highly Influential
  • PDF
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
  • 294
  • Highly Influential
  • PDF
Contributions of KRAS and RAL in Non–Small-Cell Lung Cancer Growth and Progression
  • Sunny Guin, Y. Ru, +8 authors D. Theodorescu
  • Biology, Medicine
  • Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • 2013
  • 29
  • Highly Influential
Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET
  • 37
  • Highly Influential
  • PDF
...
1
2
3
4
5
...